New research shows inflammation outside the brain travels through tiny biological packages to drive Parkinson’s

A team of international scientists has discovered a new path that connects general body inflammation to the brain, offering a fresh explanation for how Parkinson's progresses. The study shows that the process begins when ageing or specific genetic changes cause cells to build up waste. Normally, cells recycle their own genetic material. However, in this scenario, their own DNA accumulates where it does not belong inside the cell. This buildup triggers a molecular alarm system inside the cells known as the cGAS STING pathway. Typically, this system acts as a shield against viruses by detecting foreign genetic code. When it is wrongly activated by the cells own leftover DNA, it sets off a chronic inflammatory response. The researchers found that cells package this misplaced DNA into tiny biological envelopes called extracellular vesicles. These small packages are released into the bloodstream and can travel vast distances. Crucially, they can cross the protective barrier between the bloodstream and the brain. Once inside the brain, they trigger the same cGAS STING alarm system in brain cells, causing inflammation to spread. During experiments with mice carrying a genetic mutation linked to Parkinson's, the scientists observed a significant loss of the brain cells responsible for movement. However, when the team deactivated the STING alarm system, the inflammation stopped. The mice were protected from both brain cell loss and the decline in physical movement. To see if this applies to humans, the researchers analysed blood and spinal fluid from people living with Parkinson's. They found that these samples contained much higher levels of the DNA carrying vesicles compared to healthy individuals. Furthermore, these human packages triggered the exact same inflammatory response when tested. This discovery highlights how a problem starting in the body can slowly smoulder and eventually ignite inflammation in the brain. By showing that the immune system or other tissues can actively drive brain cell damage, the research opens up exciting new possibilities for therapies. Instead of only targeting the brain, future treatments might be able to halt the condition by calming inflammation in the rest of the body first.